2 unknown, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Not yet recruiting 1 |
Follow DWP16001 Placebo: new trials by email Literature Review of DWP16001 Placebo trials Research Report on DWP16001 Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients DWP16001 Placebo, DWP16001 0.3mg - Type 2 Diabetic Nephropathy | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 348 | 2024-09-23 | 2024-09-20 |
| A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus DWP16001 0.3mg, DWP16001 Placebo - Type 2 Diabetes Mellitus | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 240 | 2023-03-17 | 2024-04-08 |
| The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin DWP16001, Dapagliflozin, DWP16001 Placebo - Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 340 | 2022-09-28 | 2024-04-04 |
Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
Daewoong Pharmaceutical Co. LTD. (3)
South Korea (2) · China (1)
Linong Ji, Dr. (1)